Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Global X MSCI SuperDividend EAFE ETF | EFAS | Jan 30, 2025 | 14.55 | +0.59 |
Global X Robotics & Artificial Intelligence Thematic ETF | BOTZ | Jan 30, 2025 | 33.45 | +0.36 |
Global X S&P 500 Catholic Values ETF | CATH | Jan 30, 2025 | 73.19 | +0.56 |
Global X Super Dividend ETF | DIV | Jan 30, 2025 | 18.75 | +1.24 |
Global X SuperDividend Alternatives ETF | ALTY | Jan 30, 2025 | 11.94 | +0.65 |
Global X SuperDividend REIT ETF | SRET | Jan 30, 2025 | 20.39 | +0.49 |
Global X Superincome Preferred | SPFF | Jan 30, 2025 | 9.45 | +0.48 |
Global X Telemedicine & Digital Health ETF | EDOC | Jan 30, 2025 | 10.93 | +1.86 |
Global-E Online | GLBE | Jan 30, 2025 | 60.64 | +0.23 |
GLOBALFOUNDRIES | GFS | Jan 30, 2025 | 41.50 | +0.29 |
Globalstar | GSAT | Jan 30, 2025 | 1.48 | -5.73 |
Globant | GLOB | Jan 30, 2025 | 207.03 | -0.52 |
Globavend | GVH | Jan 30, 2025 | 0.67 | -4.29 |
Globe Life | GL | Jan 30, 2025 | 122.30 | +0.29 |
Globus Maritime | GLBS | Jan 30, 2025 | 1.41 | +0.05 |
Globus Medical A | GMED | Jan 30, 2025 | 93.12 | +0.36 |
GlucoTrack | GCTK | Jan 30, 2025 | 0.07 | -24.06 |
GlycoMimetics | GLYC | Jan 30, 2025 | 0.29 | +13.86 |
GMS | GMS | Jan 30, 2025 | 86.13 | +1.33 |
GNMA Bond Ishares | GNMA | Jan 30, 2025 | 43.24 | +0.08 |
GoDaddy A | GDDY | Jan 30, 2025 | 213.53 | -0.18 |
Gogo | GOGO | Jan 30, 2025 | 8.35 | +0.97 |
Gogoro | GGR | Jan 30, 2025 | 0.42 | +0.75 |
GoHealth A | GOCO | Jan 30, 2025 | 16.22 | +1.31 |
Golar Lng | GLNG | Jan 30, 2025 | 40.61 | +2.04 |
Gold and Silver Sector Index | XAU | Jan 30, 2025 | 156.06 | +4.01 |
Gold Fields ADR | GFI | Jan 30, 2025 | 17.28 | +4.16 |
Gold Miners Bear 3X Direxion | DUST | Jan 30, 2025 | 50.51 | -8.00 |
Gold Miners Bull 3X Direxion | NUGT | Jan 30, 2025 | 46.75 | +7.92 |
Gold Miners ETF Market Vectors | GDX | Jan 30, 2025 | 39.42 | +4.01 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.